Verrica Pharmaceuticals
VRCA
#9503
Rank
ยฃ57.42 M
Marketcap
ยฃ6.05
Share price
-2.42%
Change (1 day)
-18.80%
Change (1 year)

Revenue for Verrica Pharmaceuticals (VRCA)

Revenue in 2025 (TTM): ยฃ10.85 Million

According to Verrica Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ11.02 Million. In 2024 the company made a revenue of ยฃ6.02 Million an increase over the revenue in the year 2023 that were of ยฃ4.02 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Verrica Pharmaceuticals from 2017 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ10.85 M80.04%
2024 ยฃ6.02 M49.9%
2023 ยฃ4.02 M-46.13%
2022 ยฃ7.46 M-16.02%
2021 ยฃ8.88 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A